{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:54:34Z","timestamp":1791122074753,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11563-w","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T08:02:44Z","timestamp":1777190564000},"page":"8061-8085","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In silico discovery of natural and synthetic inhibitors targeting AKT1 in prostate cancer"],"prefix":"10.1007","volume":"30","author":[{"given":"Hemantha Mani Kumar Chakravarthi","family":"Chanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudheer Kumar","family":"Katari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"key":"11563_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10:63","journal-title":"World J Oncol"},{"key":"11563_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello RJ, Oing C, Knudsen KE et al (2021) Prostate cancer. Nat Rev Dis Primers 7:9. https:\/\/doi.org\/10.1038\/s41572-020-00243-0","journal-title":"Nat Rev Dis Primers"},{"key":"11563_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.04.021","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K et al (2023) 2022 update on prostate cancer epidemiology and risk factors\u2014a systematic review. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2023.04.021","journal-title":"Eur Urol"},{"key":"11563_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41391-023-00667-1","volume":"27","author":"Y Liadi","year":"2024","unstructured":"Liadi Y, Campbell T, Dike P et al (2024) Prostate cancer metastasis and health disparities: a systematic review. Prostate Cancer Prostatic Dis 27:183\u2013191","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"11563_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01856-7","volume":"9","author":"B Liu","year":"2024","unstructured":"Liu B, Zhou H, Tan L et al (2024) Exploring treatment options in cancer: tumor treatment strategies. Signal Transduct Target Ther 9:175. https:\/\/doi.org\/10.1038\/s41392-024-01856-7","journal-title":"Signal Transduct Target Ther"},{"key":"11563_CR6","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.3390\/ijms21124507","volume":"21","author":"BY Shorning","year":"2020","unstructured":"Shorning BY, Dass MS, Smalley MJ, Pearson HB (2020) The PI3K-AKT-mTOR pathway and prostate cancer: At the crossroads of AR, MAPK, and WNT signaling. Int J Mol Sci 21:4507","journal-title":"Int J Mol Sci"},{"key":"11563_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-022-01042-7","volume":"7","author":"Y He","year":"2022","unstructured":"He Y, Xu W, Xiao YT et al (2022) Targeting signaling pathways in prostate cancer: mechanisms and clinical trials. Signal Transduct Target Ther 7:198","journal-title":"Signal Transduct Target Ther"},{"key":"11563_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG et al (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther 6:425","journal-title":"Signal Transduct Target Ther"},{"key":"11563_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/nrc839","author":"I Vivanco","year":"2002","unstructured":"Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-kinase-AKT pathway in humancancer. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/nrc839","journal-title":"Nat Rev Cancer"},{"key":"11563_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41388-024-03224-9","volume":"44","author":"C Lyu","year":"2025","unstructured":"Lyu C, Vaddi PK, Elshafae S et al (2025) Unveiling RACK1: a key regulator of the PI3K\/AKT pathway in prostate cancer development. Oncogene 44:322\u2013335. https:\/\/doi.org\/10.1038\/s41388-024-03224-9","journal-title":"Oncogene"},{"key":"11563_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41580-018-0015-0","volume":"19","author":"YR Lee","year":"2018","unstructured":"Lee YR, Chen M, Pandolfi PP (2018) The functions and regulation of the PTEN tumour suppressor: new modes and prospects. Nat Rev Mol Cell Biol 19:547","journal-title":"Nat Rev Mol Cell Biol"},{"key":"11563_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03433-0","author":"X Wan","year":"2021","unstructured":"Wan X, Zhou M, Huang F et al (2021) AKT1-CREB stimulation of PDGFR\u03b1 expression is pivotal for PTEN deficient tumor development. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-021-03433-0","journal-title":"Cell Death Dis"},{"key":"11563_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.136","author":"M Saji","year":"2011","unstructured":"Saji M, Narahara K, McCarty SK et al (2011) Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancer. Oncogene. https:\/\/doi.org\/10.1038\/onc.2011.136","journal-title":"Oncogene"},{"key":"11563_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603184","author":"C Le Page","year":"2006","unstructured":"Le Page C, Koumakpayi IH, Alam-Fahmy M et al (2006) Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients. Br J Cancer. https:\/\/doi.org\/10.1038\/sj.bjc.6603184","journal-title":"Br J Cancer"},{"key":"11563_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-022-00446-y","author":"Y Fu","year":"2023","unstructured":"Fu Y, Cao T, Zou X et al (2023) AKT1 regulates UHRF1 protein stability and promotes the resistance to abiraterone in prostate cancer. Oncogenesis. https:\/\/doi.org\/10.1038\/s41389-022-00446-y","journal-title":"Oncogenesis"},{"key":"11563_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.20892\/j.issn.2095-3941.2020.0747","volume":"19","author":"B Ma","year":"2022","unstructured":"Ma B, Shao H, Jiang X et al (2022) Akt isoforms differentially provide for chemoresistance in prostate cancer. Cancer Biol Med 19:635","journal-title":"Cancer Biol Med"},{"key":"11563_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29638-1","author":"T Shrestha Bhattarai","year":"2022","unstructured":"Shrestha Bhattarai T, Shamu T, Gorelick AN et al (2022) AKT mutant allele-specific activation dictates pharmacologic sensitivities. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-022-29638-1","journal-title":"Nat Commun"},{"key":"11563_CR18","doi-asserted-by":"publisher","first-page":"573599","DOI":"10.3389\/fcell.2020.573599","volume":"8","author":"Y Chen","year":"2020","unstructured":"Chen Y, Huang L, Dong Y et al (2020) Effect of AKT1 (p E17K) Hotspot Mutation on Malignant Tumorigenesis and Prognosis. Front Cell Dev Biol 8:573599","journal-title":"Front Cell Dev Biol"},{"key":"11563_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03207-4","volume":"43","author":"D Hassan","year":"2024","unstructured":"Hassan D, Menges CW, Testa JR, Bellacosa A (2024) AKT kinases as therapeutic targets. J Exp Clin Cancer Res 43:313","journal-title":"J Exp Clin Cancer Res"},{"key":"11563_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19689-0","author":"S Duggal","year":"2018","unstructured":"Duggal S, Jailkhani N, Midha MK et al (2018) Defining the Akt1 interactome and its role in regulating the cell cycle. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-018-19689-0","journal-title":"Sci Rep"},{"key":"11563_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.07.003","author":"N Chu","year":"2018","unstructured":"Chu N, Salguero AL, Liu AZ et al (2018) Akt kinase activation mechanisms revealed using protein semisynthesis. Cell. https:\/\/doi.org\/10.1016\/j.cell.2018.07.003","journal-title":"Cell"},{"key":"11563_CR22","doi-asserted-by":"publisher","first-page":"104270","DOI":"10.1016\/j.phrs.2019.104270","volume":"145","author":"A Alwhaibi","year":"2019","unstructured":"Alwhaibi A, Verma A, Adil MS, Somanath PR (2019) The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis. Pharmacol Res 145:104270","journal-title":"Pharmacol Res"},{"key":"11563_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06128-9","author":"G Rao","year":"2017","unstructured":"Rao G, Pierobon M, Kim IK et al (2017) Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-017-06128-9","journal-title":"Sci Rep"},{"key":"11563_CR24","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s43018-024-00839-5","volume":"5","author":"KK Youssef","year":"2024","unstructured":"Youssef KK, Narwade N, Arcas A et al (2024) Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations. Nat Cancer 5:1660\u20131680. https:\/\/doi.org\/10.1038\/s43018-024-00839-5","journal-title":"Nat Cancer"},{"key":"11563_CR25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1941","author":"CW Li","year":"2016","unstructured":"Li CW, Xia W, Lim SO et al (2016) AKT1 inhibits epithelial-to-mesenchymal transition in breast cancer through phosphorylation-dependent twist1 degradation. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1941","journal-title":"Cancer Res"},{"key":"11563_CR26","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-10-0204","author":"S Ha","year":"2011","unstructured":"Ha S, Ruoff R, Kahoud N et al (2011) Androgen receptor levels are upregulated by Akt in prostate cancer. Endocr Relat Cancer. https:\/\/doi.org\/10.1530\/ERC-10-0204","journal-title":"Endocr Relat Cancer"},{"key":"11563_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41586-024-08176-4","volume":"637","author":"GB Craven","year":"2025","unstructured":"Craven GB, Chu H, Sun JD et al (2025) Mutant-selective AKT inhibition through lysine targeting and neo-zinc chelation. Nature 637:205\u2013214. https:\/\/doi.org\/10.1038\/s41586-024-08176-4","journal-title":"Nature"},{"key":"11563_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-83912-4","volume":"14","author":"L Stevenson","year":"2024","unstructured":"Stevenson L, Cairns L, Li X et al (2024) Inhibition of AKT enhances chemotherapy efficacy and synergistically interacts with targeting of the inhibitor of apoptosis proteins in oesophageal adenocarcinoma. Sci Rep 14:32121. https:\/\/doi.org\/10.1038\/s41598-024-83912-4","journal-title":"Sci Rep"},{"key":"11563_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46312-7","author":"H Takemura","year":"2019","unstructured":"Takemura H, Choi JH, Matsuzaki N et al (2019) A fairy chemical, Imidazole-4-carboxamide, is produced on a novel purine metabolic pathway in rice. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-019-46312-7","journal-title":"Sci Rep"},{"key":"11563_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jinorgbio.2018.11.009","volume":"191","author":"P R\u00f6thlisberger","year":"2019","unstructured":"R\u00f6thlisberger P, Levi-Acobas F, Sarac I et al (2019) Towards the enzymatic formation of artificial metal base pairs with a carboxy-imidazole-modified nucleotide. J Inorg Biochem 191:154\u2013163. https:\/\/doi.org\/10.1016\/j.jinorgbio.2018.11.009","journal-title":"J Inorg Biochem"},{"key":"11563_CR31","doi-asserted-by":"publisher","DOI":"10.2174\/1570179418666210809131917","author":"S Ahmad","year":"2021","unstructured":"Ahmad S, Akhtar R, Zahoor AF (2021) Comprehensive Account on the Synthesis of (-)-Balanol and its Analogues. Curr Org Synth. https:\/\/doi.org\/10.2174\/1570179418666210809131917","journal-title":"Curr Org Synth"},{"key":"11563_CR32","doi-asserted-by":"publisher","DOI":"10.1021\/jo952280k","author":"JW Lampe","year":"1996","unstructured":"Lampe JW, Hughes PF, Biggers CK et al (1996) Total synthesis of (-)\u00b7 and (+)-balanol. J Org Chem. https:\/\/doi.org\/10.1021\/jo952280k","journal-title":"J Org Chem"},{"key":"11563_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0224-2","author":"D Romero","year":"2019","unstructured":"Romero D (2019) HDAC inhibitors tested in phase III trial. Nat Rev Clin Oncol. https:\/\/doi.org\/10.1038\/s41571-019-0224-2","journal-title":"Nat Rev Clin Oncol"},{"key":"11563_CR34","doi-asserted-by":"publisher","first-page":"932914","DOI":"10.3389\/fphar.2022.932914","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, Hong JH, Ning Z et al (2022) Therapeutic potential of tucidinostat, a subtype-selective HDAC inhibitor, in cancer treatment. Front Pharmacol 13:932914","journal-title":"Front Pharmacol"},{"key":"11563_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202004004","author":"N Kratena","year":"2021","unstructured":"Kratena N, G\u00f6kler T, Maltrovsky L et al (2021) A unified approach to phytosiderophore natural products. Chem Eur J. https:\/\/doi.org\/10.1002\/chem.202004004","journal-title":"Chem Eur J"},{"key":"11563_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21837-6","author":"M Suzuki","year":"2021","unstructured":"Suzuki M, Urabe A, Sasaki S et al (2021) Development of a mugineic acid family phytosiderophore analog as an iron fertilizer. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-021-21837-6","journal-title":"Nat Commun"},{"key":"11563_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22631-z","author":"K Mohanraj","year":"2018","unstructured":"Mohanraj K, Karthikeyan BS, Vivek-Ananth RP et al (2018) IMPPAT: a curated database of Indian medicinal plants, phytochemistry and therapeutics. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-018-22631-z","journal-title":"Sci Rep"},{"key":"11563_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad976","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM et al (2024) DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkad976","journal-title":"Nucleic Acids Res"},{"key":"11563_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2016.051","author":"S Forli","year":"2016","unstructured":"Forli S, Huey R, Pique ME et al (2016) Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc. https:\/\/doi.org\/10.1038\/nprot.2016.051","journal-title":"Nat Protoc"},{"key":"11563_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35132-5","author":"T Chen","year":"2023","unstructured":"Chen T, Shu X, Zhou H et al (2023) Algorithm selection for protein\u2013ligand docking: strategies and analysis on ACE. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-023-35132-5","journal-title":"Sci Rep"},{"key":"11563_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s44386-025-00005-6","volume":"2","author":"M Xue","year":"2025","unstructured":"Xue M, Liu B, Cao S, Huang X (2025) FeatureDock for protein-ligand docking guided by physicochemical feature-based local environment learning using transformer. npj Drug Discov 2:4. https:\/\/doi.org\/10.1038\/s44386-025-00005-6","journal-title":"npj Drug Discov"},{"key":"11563_CR42","doi-asserted-by":"publisher","DOI":"10.1107\/S2059798321007531","author":"N Bouatta","year":"2021","unstructured":"Bouatta N, Sorger P, AlQuraishi M (2021) Protein structure prediction by AlphaFold2: Are attention and symmetries all you need? Acta Crystallogr D Struct Biol. https:\/\/doi.org\/10.1107\/S2059798321007531","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"11563_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4530","author":"M Holcomb","year":"2023","unstructured":"Holcomb M, Chang YT, Goodsell DS, Forli S (2023) Evaluation of AlphaFold2 structures as docking targets. Protein Sci. https:\/\/doi.org\/10.1002\/pro.4530","journal-title":"Protein Sci"},{"key":"11563_CR44","first-page":"26","volume-title":"Artificial intelligence: a multidisciplinary approach towards teaching and learning","author":"HMC Chanda","year":"2024","unstructured":"Chanda HMC, Mulpuru V, Mishra N (2024) Artificial intelligence and bioinformatics: a powerful synergy for drug design and discovery. Artificial intelligence: a multidisciplinary approach towards teaching and learning. Bentham Science Publishers, Singapore, pp 26\u201379"},{"key":"11563_CR45","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.1c00203","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203","journal-title":"J Chem Inf Model"},{"key":"11563_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04268-7","author":"RJ Gardner","year":"2022","unstructured":"Gardner RJ, Hermansen E, Pachitariu M et al (2022) Toroidal topology of population activity in grid cells. Nature. https:\/\/doi.org\/10.1038\/s41586-021-04268-7","journal-title":"Nature"},{"key":"11563_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/slct.201702392","author":"V Asati","year":"2018","unstructured":"Asati V, Thakur SS, Upmanyu N, Bharti SK (2018) Virtual screening, molecular docking, and DFT studies of some thiazolidine-2,4-diones as potential PIM-1 kinase inhibitors. Chem Select. https:\/\/doi.org\/10.1002\/slct.201702392","journal-title":"Chem Select"},{"key":"11563_CR48","doi-asserted-by":"publisher","DOI":"10.1515\/cppm-2025-0035","author":"HMKC Chanda","year":"2025","unstructured":"Chanda HMKC, Narra HP, Katari SK (2025) In Silico target identification and drug discovery for 5-proFAR isomerase inhibitors in critical fungal pathogens. Chem Product Proc Model. https:\/\/doi.org\/10.1515\/cppm-2025-0035","journal-title":"Chem Product Proc Model"},{"key":"11563_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52061-7","volume":"15","author":"G Zhou","year":"2024","unstructured":"Zhou G, Rusnac D-V, Park H et al (2024) An artificial intelligence accelerated virtual screening platform for drug discovery. Nat Commun 15:7761. https:\/\/doi.org\/10.1038\/s41467-024-52061-7","journal-title":"Nat Commun"},{"key":"11563_CR50","volume-title":"Methods in molecular biology","author":"G Bitencourt-Ferreira","year":"2019","unstructured":"Bitencourt-Ferreira G, Pintro VO, de Azevedo WF (2019) Docking with AutoDock4. Methods in molecular biology"},{"key":"11563_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"11563_CR52","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1021\/ci500467k","volume":"54","author":"A Daina","year":"2014","unstructured":"Daina A, Michielin O, Zoete V (2014) iLOGP: a simple, robust, and efficient description of n-Octanol\/Water partition coefficient for drug design using the GB\/SA approach. J Chem Inf Model 54:3284\u20133301. https:\/\/doi.org\/10.1021\/ci500467k","journal-title":"J Chem Inf Model"},{"key":"11563_CR53","volume-title":"Computational approaches for novel therapeutic and diagnostic designing to mitigate SARS-CoV2 infection: revolutionary strategies to combat pandemics","author":"P Sucharitha","year":"2022","unstructured":"Sucharitha P, Reddy RK, Satyanarayana SV, Garg T (2022) Absorption, distribution, metabolism, excretion, and toxicity assessment of drugs using computational tools. Computational approaches for novel therapeutic and diagnostic designing to mitigate SARS-CoV2 infection: revolutionary strategies to combat pandemics"},{"key":"11563_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.crstbi.2024.100124","author":"B Saha","year":"2024","unstructured":"Saha B, Das A, Jangid K et al (2024) Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer\u2019s disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM\/GBSA, ADME and MD simulation study. Curr Res Struct Biol. https:\/\/doi.org\/10.1016\/j.crstbi.2024.100124","journal-title":"Curr Res Struct Biol"},{"key":"11563_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106750","author":"SP Ritu","year":"2023","unstructured":"Ritu SP, Gupta GD, Asati V (2023) Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as \u03b1-glucosidase inhibitors. Bioorg Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106750","journal-title":"Bioorg Chem"},{"key":"11563_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72435-7","volume":"14","author":"R Badry","year":"2024","unstructured":"Badry R, Elhaes H, Ibrahim A et al (2024) Investigating the electronic properties and reactivity of polyaniline emeraldine base functionalized with metal oxides. Sci Rep 14:27024. https:\/\/doi.org\/10.1038\/s41598-024-72435-7","journal-title":"Sci Rep"},{"key":"11563_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72846-6","volume":"14","author":"NM Sabry","year":"2024","unstructured":"Sabry NM, Badry R, Abdel-Gawad FKh et al (2024) Electronic structure, global reactivity descriptors and nonlinear optical properties of glycine interacted with ZnO, MgO and CaO for bacterial detection. Sci Rep 14:22801. https:\/\/doi.org\/10.1038\/s41598-024-72846-6","journal-title":"Sci Rep"},{"key":"11563_CR58","unstructured":"Frisch MJ, Trucks GW, Schlegel HB, et al (2016) Gaussian\u02dc16 Revision C.01"},{"key":"11563_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41524-024-01403-6","volume":"10","author":"X Peng","year":"2024","unstructured":"Peng X, Liang J, Wang K et al (2024) Construction frontier molecular orbital prediction model with transfer learning for organic materials. npj Comput Mater 10:213. https:\/\/doi.org\/10.1038\/s41524-024-01403-6","journal-title":"npj Comput Mater"},{"key":"11563_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.135596","author":"S Gupta","year":"2023","unstructured":"Gupta S, Baweja GS, Gupta GD, Asati V (2023) Identification of potential N-substituted 5-benzylidenethiazolidine-2,4-dione derivatives as \u03b1-amylase inhibitors: Computational cum synthetic studies. J Mol Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2023.135596","journal-title":"J Mol Struct"},{"key":"11563_CR61","doi-asserted-by":"publisher","DOI":"10.5530\/ijper.51.3.72","author":"V Asati","year":"2017","unstructured":"Asati V, Bharti SK, Rathore A, Mahapatra DK (2017) SWFB and GA strategies for variable selection in qsar studies for the validation of thiazolidine-2,4-dione derivatives as promising antitumor candidates. Indian J Pharmac Edu Res. https:\/\/doi.org\/10.5530\/ijper.51.3.72","journal-title":"Indian J Pharmac Edu Res"},{"key":"11563_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45461-2","author":"W Lu","year":"2024","unstructured":"Lu W, Zhang J, Huang W et al (2024) DynamicBind: predicting ligand-specific protein-ligand complex structure with a deep equivariant generative model. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-024-45461-2","journal-title":"Nat Commun"},{"key":"11563_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59899-3","volume":"14","author":"DT Truong","year":"2024","unstructured":"Truong DT, Ho K, Pham DQH et al (2024) Treatment of flexibility of protein backbone in simulations of protein\u2013ligand interactions using steered molecular dynamics. Sci Rep 14:10475. https:\/\/doi.org\/10.1038\/s41598-024-59899-3","journal-title":"Sci Rep"},{"key":"11563_CR64","doi-asserted-by":"crossref","unstructured":"Bowers KJ, Chow E, Xu H, et al (2006) Scalable algorithms for molecular dynamics simulations on commodity clusters. In: Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing. pp 84-es","DOI":"10.1145\/1188455.1188544"},{"key":"11563_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2021.115899","author":"HT Xu","year":"2021","unstructured":"Xu HT, Zhang N, Li MR, Zhang FS (2021) Anion effect of Cl\u2212, I\u2212, and F\u2212 on counterions condensation within nucleic acid ion atmosphere. J Mol Liq. https:\/\/doi.org\/10.1016\/j.molliq.2021.115899","journal-title":"J Mol Liq"},{"key":"11563_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55404-6","volume":"16","author":"C Zhang","year":"2025","unstructured":"Zhang C, Tian F-J, Zuo H-W et al (2025) Counterintuitive DNA destabilization by monovalent salt at high concentrations due to overcharging. Nat Commun 16:113. https:\/\/doi.org\/10.1038\/s41467-024-55404-6","journal-title":"Nat Commun"},{"key":"11563_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.131079","author":"A Anant","year":"2021","unstructured":"Anant A, Ali A, Ali A et al (2021) A Computational approach to discover potential quinazoline derivatives against CDK4\/6 kinase. J Mol Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2021.131079","journal-title":"J Mol Struct"},{"key":"11563_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s40203-022-00121-5","volume":"10","author":"A Rathore","year":"2022","unstructured":"Rathore A, Asati V, Mishra M et al (2022) Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia. In Silico Pharmacol 10:7. https:\/\/doi.org\/10.1007\/s40203-022-00121-5","journal-title":"In Silico Pharmacol"},{"key":"11563_CR69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1063\/5.0251642","volume":"162","author":"J Jung","year":"2025","unstructured":"Jung J, Sugita Y (2025) Langevin integration for isothermal\u2013isobaric condition with a large time step. J Chem Phys 162:7","journal-title":"J Chem Phys"},{"key":"11563_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49858-x","volume":"15","author":"X Song","year":"2024","unstructured":"Song X, Bao L, Feng C et al (2024) Accurate prediction of protein structural flexibility by deep learning integrating intricate atomic structures and Cryo-EM density information. Nat Commun 15:5538. https:\/\/doi.org\/10.1038\/s41467-024-49858-x","journal-title":"Nat Commun"},{"key":"11563_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3923","author":"BJ Grant","year":"2021","unstructured":"Grant BJ, Skj\u00e6rven L, Yao XQ (2021) The Bio3D packages for structural bioinformatics. Protein Sci. https:\/\/doi.org\/10.1002\/pro.3923","journal-title":"Protein Sci"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11563-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11563-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11563-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:47:46Z","timestamp":1791121666000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11563-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":71,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11563"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11563-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7627265\/v1","asserted-by":"object"}]},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}